Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B
Journal
Hepatology international
Journal Volume
17
Journal Issue
5
Pages
1139 - 1149
Date Issued
2023-05-29
Abstract
Chronic hepatitis B (CHB) and metabolic dysfunction-associated fatty liver disease (MAFLD) are the leading causes of hepatocellular carcinoma (HCC). We aim to explore the impact of concurrent MAFLD on the risk of HCC in CHB.
Subjects
Hepatitis B virus (HBV); Liver cancer; Metabolic dysfunction-associated fatty liver disease (MAFLD); Metabolic syndrome; Non-alcoholic fatty liver disease (NAFLD)
SDGs
Publisher
SPRINGER
Type
journal article